Care of patients with hemoglobin disorders during the COVID-19 pandemic: An overview of recommendations.
作者信息
Taher Ali T, Bou-Fakhredin Rayan, Kreidieh Firas, Motta Irene, De Franceschi Lucia, Cappellini Maria Domenica
机构信息
Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
出版信息
Am J Hematol. 2020 Aug;95(8):E208-E210. doi: 10.1002/ajh.25857. Epub 2020 May 21.
Abstract
摘要
相似文献
1
Care of patients with hemoglobin disorders during the COVID-19 pandemic: An overview of recommendations.2019冠状病毒病大流行期间血红蛋白异常患者的护理：建议概述
Am J Hematol. 2020 Aug;95(8):E208-E210. doi: 10.1002/ajh.25857. Epub 2020 May 21.
2
Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries.减轻新冠疫情对非洲国家镰状细胞病服务的影响。
Lancet Haematol. 2020 Jun;7(6):e430-e432. doi: 10.1016/S2352-3026(20)30122-8. Epub 2020 Apr 23.
3
Vulnerability of sickle cell disease persons to the COVID-19 in sub-Saharan Africa.撒哈拉以南非洲地区镰状细胞病患者感染新冠病毒的易感性。
Hematology. 2020 Dec;25(1):280-282. doi: 10.1080/16078454.2020.1790842.
4
Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19).2019新型冠状病毒病（COVID-19）所致镰状细胞病的血管闭塞性危机和急性胸综合征
Am J Hematol. 2020 Jun;95(6):725-726. doi: 10.1002/ajh.25821. Epub 2020 Apr 21.
5
Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.新型冠状病毒肺炎感染对24例镰状细胞病患者的影响。美国密歇根州底特律市一家中心的城市经验。
Hemoglobin. 2020 Jul;44(4):284-289. doi: 10.1080/03630269.2020.1797775. Epub 2020 Jul 28.
6
A hospital-based COVID-19 abortion case in the early phase of the pandemic.医院在大流行早期的 COVID-19 流产病例。
Contraception. 2020 Aug;102(2):137-138. doi: 10.1016/j.contraception.2020.05.005. Epub 2020 May 19.
7
A hundred days into the coronavirus disease (COVID-19) pandemic.新型冠状病毒肺炎（COVID-19）疫情爆发一百天之际。
Euro Surveill. 2020 Apr;25(14). doi: 10.2807/1560-7917.ES.2020.25.14.2000550.
8
Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20-May 21, 2020.2020 年 3 月 20 日至 5 月 21 日美国镰状细胞病患者中的冠状病毒病。
Emerg Infect Dis. 2020 Oct;26(10):2473-2476. doi: 10.3201/eid2610.202792. Epub 2020 Jul 8.
9
COVID-19 pandemic.新冠疫情
Rev Bras Ter Intensiva. 2020 Mar;32(1):1. doi: 10.5935/0103-507x.20200001. Epub 2020 May 8.
10
Self-care recommendations for patients with rheumatic diseases during the COVID-19 pandemic.2019冠状病毒病大流行期间风湿病患者的自我护理建议。
Rheumatol Int. 2020 Aug;40(8):1347-1349. doi: 10.1007/s00296-020-04614-4. Epub 2020 Jun 2.
引用本文的文献
1
The clinical course and risk factors in COVID-19 patients with acute kidney injury.新型冠状病毒肺炎合并急性肾损伤患者的临床病程及危险因素
J Family Med Prim Care. 2022 Oct;11(10):6183-6189. doi: 10.4103/jfmpc.jfmpc_231_22. Epub 2022 Oct 31.
2
Systemic Steroids and the Risk of Vasoocclusive Events in Patients with Sickle Cell Disease.全身性类固醇与镰状细胞病患者血管闭塞性事件的风险
Ann Am Thorac Soc. 2023 Jan;20(1):18-20. doi: 10.1513/AnnalsATS.202207-627PS.
3
COVID-19 pandemic and care of transfusion-dependent patients of thalassaemia: Experience from a paediatric centre in North India.COVID-19 大流行与依赖输血的地中海贫血患者的护理：来自印度北部一家儿科中心的经验。
J Paediatr Child Health. 2022 Oct;58(10):1760-1765. doi: 10.1111/jpc.16082. Epub 2022 Jul 5.
4
Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies.BNT162b2新冠mRNA疫苗和ChAdOx1 nCoV-19疫苗在血红蛋白病患者中的免疫原性
Vaccines (Basel). 2022 Jan 20;10(2):151. doi: 10.3390/vaccines10020151.
5
From H1N1 to COVID-19: What we have seen in children with hemoglobinopathies.从 H1N1 到 COVID-19：我们在患有血红蛋白病的儿童中看到的情况。
Clinics (Sao Paulo). 2022 Jan 29;77:100004. doi: 10.1016/j.clinsp.2021.100004. eCollection 2022.
6
The overall impact of COVID-19 on healthcare during the pandemic: A multidisciplinary point of view.新冠疫情期间COVID-19对医疗保健的总体影响：多学科视角
Health Sci Rep. 2021 Oct 1;4(4):e386. doi: 10.1002/hsr2.386. eCollection 2021 Dec.
7
The EHA Research Roadmap: Anemias.欧洲血液学协会研究路线图：贫血症
Hemasphere. 2021 Jun 30;5(7):e607. doi: 10.1097/HS9.0000000000000607. eCollection 2021 Jul.
8
Presentation, management, and outcomes of COVID-19 in patients with sickle cell disease.镰状细胞病患者中新型冠状病毒肺炎的临床表现、治疗及预后
EJHaem. 2021 Feb;2(1):124-127. doi: 10.1002/jha2.162. Epub 2021 Jan 12.
9
Indian Society of Hematology and Blood Transfusion (ISHBT) Consensus Document on Hematological Practice During COVID-19 Pandemic.印度血液学与输血学会（ISHBT）关于COVID-19大流行期间血液学实践的共识文件。
Indian J Hematol Blood Transfus. 2021 Jan;37(1):1-9. doi: 10.1007/s12288-021-01405-0. Epub 2021 Feb 16.
10
Coagulation Abnormalities Due to COVID-19 in a Child with Thalassemia.一名地中海贫血患儿因新冠病毒感染导致的凝血异常
Indian J Pediatr. 2021 Apr;88(4):396-397. doi: 10.1007/s12098-020-03600-9. Epub 2021 Jan 8.
本文引用的文献
1
Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic.在 COVID-19 大流行期间，保护患有遗传性贫血的脆弱患者免于不必要的死亡。
Br J Haematol. 2020 May;189(4):635-639. doi: 10.1111/bjh.16687. Epub 2020 May 10.
2
COVID-19 infection in patients with sickle cell disease.镰状细胞病患者的新型冠状病毒肺炎感染
Br J Haematol. 2020 Jun;189(5):851-852. doi: 10.1111/bjh.16734. Epub 2020 May 8.
3
SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience.β地中海贫血患者的新型冠状病毒2型感染：来自意大利经验的初步数据。
Am J Hematol. 2020 Aug;95(8):E198-E199. doi: 10.1002/ajh.25840. Epub 2020 May 6.
4
Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab.一名镰状细胞病患者出现快速进展且严重的新冠病毒肺炎并伴有严重急性胸部综合征，使用托珠单抗成功治疗。
Am J Hematol. 2020 Jul;95(7):876-878. doi: 10.1002/ajh.25833. Epub 2020 May 12.
5
Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic.在 COVID-19 大流行期间，为 SCA 患儿启动预防中风的辅助低剂量羟基脲治疗。
Blood. 2020 May 28;135(22):1997-1999. doi: 10.1182/blood.2020005992.
6
Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19).2019新型冠状病毒病（COVID-19）所致镰状细胞病的血管闭塞性危机和急性胸综合征
Am J Hematol. 2020 Jun;95(6):725-726. doi: 10.1002/ajh.25821. Epub 2020 Apr 21.
7
Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability.危重症新型冠状病毒肺炎感染患者表现出与高凝状态一致的凝血波形分析参数增加。
Am J Hematol. 2020 Jul;95(7):E156-E158. doi: 10.1002/ajh.25822. Epub 2020 May 4.
8
COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient.新冠病毒肺炎作为一名成年镰状细胞病患者急性胸综合征的病因
Am J Hematol. 2020 Jul;95(7):E154-E156. doi: 10.1002/ajh.25809. Epub 2020 Apr 21.
9
The outbreak of Coronavirus Disease 2019 (COVID-19)-An emerging global health threat.2019 年冠状病毒病（COVID-19）爆发-新兴的全球健康威胁。
J Infect Public Health. 2020 Apr;13(4):644-646. doi: 10.1016/j.jiph.2020.02.033. Epub 2020 Mar 19.
Zotero 插件